摘要
目的:了解我国部分地区癌痛治疗现况,进一步推动“癌症镇痛三阶梯”治疗工作。方法:采用“癌症患者疼痛情况调查表”,由主管医生逐一询问并记录填写,在北京、上海、天津、江西四地区共9家三级甲等肿瘤医院或综合性医院肿瘤中心(科)的住院及门诊病人进行癌症疼痛及相关情况调查。结果:共完成568例癌痛患者的调查。93.38%(有效应答544例)的癌症患者接受过止痛治疗。在接受止痛治疗的各种方法中,选用药物镇痛的占94.19%。镇痛药的使用率由高至低排列依次为弱阿片类镇痛药(52.99%)、强阿片类镇痛药(45.60%)和非激素类消炎止痛药(26.58%)。患者不接受使用镇痛药的原因主要有:害怕使用镇痛药成瘾;镇痛药的副作用;经济原因。结论:WHO提倡的“三阶梯止痛”临床治疗原则已在临床上得到了广泛实施,并被癌症患者所接受。
Objective： To estimate the prevalence and severity of cancer related pain, and promote the WHO project on Three-step Analgesic ladder for cancer patients. Metthods： Inpatients and outpatients at nine cancer centers or comprehensive hospitals were surveyed by using Brief Cancer Pain Inventory-Chinese in Beijing, Shanghai, Tianjin and Jiangxi, Results： Totally 568 cancer patients were investigated. The results showed that 544 effective respondents, 93.38% cancer pain patients had had analgesic therapy and among which 94.19% took analgesics for pain. The rate of utilization of weak opioid analgesics, strong oploid analgesics and NSAIDs was 52.99%, 45.60 %, 26.58 %, respectively. The reason for refusing analgesics was： fear of getting drug addicted, drug adverse effects, and economic problem.Conclustion ： The strategy of WHO＇s three-step analgesic approach is implementing in China, and accepted by cancer patients.
出处
《中国药物依赖性杂志》
CAS
CSCD
2005年第5期354-359,共6页
Chinese Journal of Drug Dependence
基金
211工程(项目编号:88103-242156044)
973项目(项目编号:2003CB515400)
关键词
癌症疼痛
三阶梯止痛
止痛药
调查
cancer pain
three-step analgesic ladder
analgesics
survey
